ArticleDiagnostics (Basel, Switzerland)2026
Is There a Tumor Proportion Score Threshold at Which Tumor-Cell PD-L1 Adds Prognostic Information Beyond the International Prognostic Index in Large B-Cell Lymphoma?
Mehmet Mutlu Kidi, Suheda Atas Ipek, Sendag Yaslikaya, Mahmut Buyuksimsek, Mehmet Turker, Yasemin Aydinalp Camadan, Sedat Biter, Tolga Koseci, Tugba Toyran, Melek Ergin and 3 more
Abstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Suheda Atas IpekDepartment of Medical Oncology, Faculty of Medicine, Cukurova University, Adana 01330, Türkiye.ORCID 0000-0003-1377-0488 Sendag YaslikayaDepartment of Medical Oncology, Giresun Training and Research Hospital, Giresun 28100, Türkiye.ORCID 0000-0001-5264-8405 Mahmut BuyuksimsekDepartment of Medical Oncology, Adana Training and Research Hospital, Adana 01330, Türkiye.ORCID 0000-0001-6356-9059 Mehmet TurkerDepartment of Medical Oncology, Adana Training and Research Hospital, Adana 01330, Türkiye.ORCID 0000-0003-4163-917X Yasemin Aydinalp CamadanDepartment of Medical Oncology, Sanliurfa Training and Research Hospital, Sanliurfa 63300, Türkiye.ORCID 0000-0003-2435-368X Tolga KoseciDepartment of Medical Oncology, Faculty of Medicine, Cukurova University, Adana 01330, Türkiye.
Tugba ToyranDepartment of Medical Pathology, Faculty of Medicine, Cukurova University, Adana 01330, Türkiye.ORCID 0000-0001-9135-0265 Melek ErginDepartment of Medical Pathology, Faculty of Medicine, Cukurova University, Adana 01330, Türkiye.
Berksoy SahinDepartment of Medical Oncology, Faculty of Medicine, Cukurova University, Adana 01330, Türkiye.
Ismail Oguz KaraDepartment of Medical Oncology, Faculty of Medicine, Cukurova University, Adana 01330, Türkiye.
Ertugrul BayramDepartment of Medical Oncology, Faculty of Medicine, Cukurova University, Adana 01330, Türkiye.ORCID 0000-0001-8713-7613 Funding
Turkish Society of Medical Oncology
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
diffuse large B-cell lymphomaimmune checkpointimmunohistochemistryInternational Prognostic Indexlarge B-cell lymphomaoverall survivalPD-L1prognosistumor proportion score
Identifiers
PMID42793820
PMCPMC13605719
What OpenQuestion holds
Textmetadata
Read underepoch 390